Apixaban Molecule, illustration

Apixaban Molecule, illustration

C028/0358 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 23.9MB

Downloadable file size: 1.1MB

Price image Pricing

Please login to use the price calculator


Caption: Molecular model of Apixaban (Eliquis). Formula: C25 H25 N5 O4. Molecular mass: 459.497 g/mol. Carbon: gray, Hydrogen: yellow; Nitrogen: blue; Oxygen: red. Apixaban (trade name Eliquis) is an anticoagulant for the prevention of venous thromboembolism and venous thromboembolic events. It is a direct factor Xa inhibitor. Apixaban was approved for the prevention of venous thromboembolism after elective hip or knee replacement in the USA by the FDA in 2012. Apixaban reduces the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.

Release details: Model release not required. Property release not required.

Keywords: 3d model, 3d molecule, anticoagulant, apixaban, chemical, chemistry, eliquis, molecular model, molecule, thromboembolic drug structure, venous thromboembolism treatment

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.